Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,299 papers from all fields of science
Search
Sign In
Create Free Account
Reversible Inhibitors of Monoamine Oxidase
Known as:
Reversible Inhibitor of Monoamine Oxidase
RIMA shows preference for the A isoenzyme
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Monoamine Oxidase Inhibitors
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone
N. Garrick
,
T. Seppala
,
M. Linnoila
,
D. Murphy
Psychopharmacology
2004
Corpus ID: 23600727
The effects of cimoxatone, a reversible inhibitor of monoamine oxidase type A (MAO-A), on the deaminated metabolites of…
Expand
2003
2003
Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone
M. Bottlaender
,
F. Dollé
,
+8 authors
H. Valette
Journal of Pharmacology and Experimental…
2003
Corpus ID: 8829137
Befloxatone is a competitive and reversible inhibitor of monoamine oxidase-A (MAOI-A). The aim of the study was to characterize…
Expand
2001
2001
Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder.
F. Schneier
2001
Corpus ID: 221336559
Background: A once-weekly enteric-coated formulation of fluoxetine represents a new, effective option for the long-term treatment…
Expand
2000
2000
Focal cerebral ischemia-induced escape deficit in rats is ameliorated by a reversible inhibitor of monoamine oxidase-a: implications for a novel animal model of post-stroke depression.
M. Kato
,
H. Iwata
,
M. Okamoto
,
T. Ishii
,
H. Narita
Biological and Pharmaceutical Bulletin
2000
Corpus ID: 2894046
The present investigation was conducted to examine whether a reversible inhibitor of monoamine oxidase (MAO)-A, T-794, affects…
Expand
Review
1998
Review
1998
Clinical pharmacology of befloxatone: a brief review.
P. Rosenzweig
,
A. Patat
,
+4 authors
E. Legangneux
Journal of Affective Disorders
1998
Corpus ID: 34764119
1997
1997
Pharmacology of the new reversible inhibitor of monoamine oxidase A, RS‐8359
N. Iwata
,
K. Püchler
,
A. Plenker
International Clinical Psychopharmacology
1997
Corpus ID: 2010327
RS-8359 is a new reversible inhibitor of monoamine oxidase A (RIMA). With a selectivity ratio of about 2200 for (ho: A:B enzyme…
Expand
1992
1992
Monoamine Oxidase Inhibitors (MAOI) or Reversible Inhibitors of Monoamine Oxidase (RIMA)/Tricyclic Antidepressant (TCA) Combination Therapy
J. Tiller
,
P. Mitchell
,
G. Burrows
Australian and New Zealand journal of psychiatry…
1992
Corpus ID: 42631059
The combination of TCA and MAOI began in the 1960s for some patients who did not seem responsive to either class of…
Expand
1985
1985
The effects of amiflamine on cerebrospinal fluid amine metabolites in the rhesus monkey.
N. Garrick
,
Timo Seppälä
,
Markku Linnoila
,
Dennis L. Murphy
European Journal of Pharmacology
1985
Corpus ID: 6582167
1983
1983
Studies on amiflamine, a reversible inhibitor of monoamine oxidase type A, selective for serotonergic neurons.
A. Ask
Acta pharmaceutica Suecica
1983
Corpus ID: 40471526
Studies on amiflamine, a reversible inhibitor of monoamine oxidase type A, selective for serotonergic neurons
1959
1959
The pharmacological evaluation of monoamine oxidase inhibitors.
A. Lessin
Biochemical Pharmacology
1959
Corpus ID: 12998210
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE